1Mason MR, Bedrossian CWM, Fahey CA, et al. Value of immunocytochemistry in study of malignant effusions[J].Diagn Cytopathol, 1987,3:215-221.
2Kaufman O, Dietel M. Thyroid transcription factor-1 is the superior immunohistochemical maker for pulmonary adenocarcinomas and large cell carcinomas compared to surfactant proteins A and B[J]. Histopathology, 2000,36(1): 8 -16.
3Myong NH. Thyroid transcription factor-l(TTF-1) expression in human lung carcinomas: its prognostic implication and relation ship with expressions of P53 and Ki67 proteins[J].J Korean Med Sei, 2003, 18(4) :494-500.
4Chenard Neu MP, Kabou A, Mechine A, et al. Immunohistochemistry in the differential diagnosis of mesothelioma and adenocarcinoma. Evaluation of 5 new antibodies and 6 traditional antibodies[J].Ann Pathol, 1998,18:460-465.
